''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"

• Status: Not yet recruiting
• Trial end date: 2021-12-31
• Target enrollment: 0
• Participant gender: All

Summary

''Evaluation of the Efficacy of Propranolol in the Treatment of Infantile Hemangioma"

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Propranolol

Criteria

Inclusion Criteria:

• Children diagnosed with problematic infantile hemangiomas:

A-Large hemangiomas at increased risk of scarring or disfigurement at any site. B-Hemangiomas carrying functional risks near the eyes, nose, natural orifices, limbs, genitalia.

C-Ulcerated infantile hemangiomas. D-Uncomplicated progressive infantile hemangiomas with unpredictable future course.

E-Life-threatening hemangiomas.

• Multiple hemangiomas

Exclusion Criteria:

• Patients older than 1 year of age.

• Patients with heart diseases.

• Patients with history of bronchspasm or wheezing.

• Patients with Hypotension.

• Patients with Hypertension.

• Premature infants with corrected age less than 5 weeks.

• Patients with conditions affecting blood glucose maintenance.

• Patients with liver failure.

• Patients with PHACES syndrome.